Concepts (106)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Career Choice | 4 | 2021 | 163 | 1.690 |
Why?
|
| Biomedical Research | 4 | 2025 | 441 | 1.370 |
Why?
|
| Students, Medical | 3 | 2017 | 455 | 1.040 |
Why?
|
| Research Personnel | 2 | 2025 | 84 | 0.860 |
Why?
|
| Education, Medical, Undergraduate | 2 | 2017 | 189 | 0.830 |
Why?
|
| Physicians | 3 | 2021 | 707 | 0.810 |
Why?
|
| Curriculum | 2 | 2017 | 615 | 0.750 |
Why?
|
| HMGB1 Protein | 2 | 2013 | 19 | 0.750 |
Why?
|
| Endothelial Cells | 2 | 2013 | 477 | 0.600 |
Why?
|
| Health Personnel | 1 | 2021 | 241 | 0.580 |
Why?
|
| Goals | 1 | 2017 | 68 | 0.500 |
Why?
|
| Attitude | 1 | 2016 | 137 | 0.450 |
Why?
|
| Internship and Residency | 3 | 2023 | 1134 | 0.410 |
Why?
|
| STAT3 Transcription Factor | 1 | 2013 | 89 | 0.400 |
Why?
|
| Capillary Permeability | 1 | 2010 | 132 | 0.320 |
Why?
|
| Cytoskeleton | 1 | 2010 | 200 | 0.300 |
Why?
|
| Pulmonary Artery | 1 | 2010 | 341 | 0.290 |
Why?
|
| Lung | 2 | 2013 | 1384 | 0.260 |
Why?
|
| Therapies, Investigational | 1 | 2005 | 18 | 0.230 |
Why?
|
| Systemic Inflammatory Response Syndrome | 1 | 2005 | 60 | 0.220 |
Why?
|
| Peripheral Blood Stem Cell Transplantation | 1 | 2005 | 67 | 0.220 |
Why?
|
| Respiratory Insufficiency | 1 | 2005 | 205 | 0.190 |
Why?
|
| Medicine | 1 | 2023 | 98 | 0.180 |
Why?
|
| Extracorporeal Membrane Oxygenation | 1 | 2005 | 217 | 0.180 |
Why?
|
| Neuroblastoma | 1 | 2005 | 400 | 0.170 |
Why?
|
| Schools, Medical | 2 | 2023 | 144 | 0.160 |
Why?
|
| Forecasting | 1 | 2021 | 317 | 0.160 |
Why?
|
| Lipopolysaccharides | 3 | 2013 | 305 | 0.140 |
Why?
|
| Cells, Cultured | 2 | 2013 | 2939 | 0.130 |
Why?
|
| Glutamine | 3 | 2001 | 99 | 0.130 |
Why?
|
| Humans | 12 | 2025 | 96105 | 0.130 |
Why?
|
| Professional Impairment | 1 | 2016 | 2 | 0.120 |
Why?
|
| Illness Behavior | 1 | 2016 | 7 | 0.120 |
Why?
|
| Adult | 5 | 2025 | 28721 | 0.120 |
Why?
|
| United States | 4 | 2025 | 7768 | 0.120 |
Why?
|
| Heat-Shock Proteins | 2 | 2010 | 184 | 0.120 |
Why?
|
| Occupational Health | 1 | 2016 | 40 | 0.120 |
Why?
|
| Male | 8 | 2025 | 45863 | 0.120 |
Why?
|
| Models, Biological | 2 | 2013 | 1809 | 0.110 |
Why?
|
| Sex Factors | 1 | 2017 | 1133 | 0.100 |
Why?
|
| Ventilator-Induced Lung Injury | 1 | 2013 | 33 | 0.100 |
Why?
|
| Longitudinal Studies | 1 | 2017 | 1176 | 0.100 |
Why?
|
| Microvessels | 1 | 2013 | 69 | 0.100 |
Why?
|
| Multiple Organ Failure | 1 | 2013 | 60 | 0.100 |
Why?
|
| Stress, Mechanical | 1 | 2013 | 261 | 0.100 |
Why?
|
| Chicago | 1 | 2017 | 1506 | 0.100 |
Why?
|
| Female | 5 | 2025 | 50028 | 0.090 |
Why?
|
| Middle Aged | 3 | 2025 | 28368 | 0.090 |
Why?
|
| Receptor for Advanced Glycation End Products | 1 | 2010 | 21 | 0.080 |
Why?
|
| HSP27 Heat-Shock Proteins | 1 | 2010 | 33 | 0.080 |
Why?
|
| Attitude of Health Personnel | 1 | 2016 | 682 | 0.080 |
Why?
|
| Stress Fibers | 1 | 2010 | 24 | 0.080 |
Why?
|
| Oxidative Stress | 1 | 2013 | 473 | 0.080 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2010 | 126 | 0.080 |
Why?
|
| Accreditation | 1 | 2011 | 74 | 0.080 |
Why?
|
| Electric Impedance | 1 | 2010 | 112 | 0.080 |
Why?
|
| Molecular Chaperones | 1 | 2010 | 127 | 0.080 |
Why?
|
| Gap Junctions | 1 | 2010 | 147 | 0.080 |
Why?
|
| Workload | 1 | 2011 | 133 | 0.080 |
Why?
|
| Gene Expression | 1 | 2013 | 1320 | 0.080 |
Why?
|
| Cadherins | 1 | 2010 | 179 | 0.080 |
Why?
|
| Antigens, CD | 1 | 2010 | 481 | 0.070 |
Why?
|
| RNA, Small Interfering | 1 | 2010 | 563 | 0.070 |
Why?
|
| Actin Cytoskeleton | 1 | 2010 | 201 | 0.070 |
Why?
|
| Recombinant Proteins | 1 | 2010 | 1034 | 0.070 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2010 | 396 | 0.070 |
Why?
|
| Phosphorylation | 1 | 2010 | 1157 | 0.070 |
Why?
|
| Actins | 1 | 2010 | 473 | 0.070 |
Why?
|
| Critical Care | 1 | 2011 | 447 | 0.060 |
Why?
|
| Education, Medical, Graduate | 1 | 2011 | 436 | 0.060 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2010 | 611 | 0.060 |
Why?
|
| Pediatrics | 1 | 2011 | 399 | 0.060 |
Why?
|
| Surveys and Questionnaires | 2 | 2025 | 2860 | 0.060 |
Why?
|
| Parental Consent | 1 | 2005 | 36 | 0.060 |
Why?
|
| Licensure | 1 | 2023 | 7 | 0.050 |
Why?
|
| Critical Illness | 1 | 2005 | 346 | 0.050 |
Why?
|
| Endotoxemia | 1 | 2001 | 19 | 0.040 |
Why?
|
| Gram-Negative Bacterial Infections | 1 | 2001 | 22 | 0.040 |
Why?
|
| Shock, Septic | 1 | 2001 | 125 | 0.040 |
Why?
|
| Signal Transduction | 1 | 2010 | 3581 | 0.040 |
Why?
|
| Burns | 1 | 2001 | 150 | 0.040 |
Why?
|
| Decision Making | 1 | 2005 | 694 | 0.040 |
Why?
|
| Cross-Sectional Studies | 1 | 2025 | 1876 | 0.040 |
Why?
|
| Pandemics | 1 | 2025 | 880 | 0.040 |
Why?
|
| Cytokines | 1 | 2001 | 871 | 0.030 |
Why?
|
| Treatment Outcome | 2 | 2005 | 9175 | 0.030 |
Why?
|
| Adolescent | 1 | 2005 | 9895 | 0.020 |
Why?
|
| Rats, Sprague-Dawley | 2 | 2001 | 1267 | 0.020 |
Why?
|
| Rats | 2 | 2001 | 4155 | 0.010 |
Why?
|
| Burn Units | 1 | 2001 | 22 | 0.010 |
Why?
|
| Interleukin-1 | 1 | 2001 | 71 | 0.010 |
Why?
|
| Nutritional Status | 1 | 2001 | 82 | 0.010 |
Why?
|
| Endotoxins | 1 | 2001 | 38 | 0.010 |
Why?
|
| Ammonia | 1 | 2001 | 45 | 0.010 |
Why?
|
| Enteral Nutrition | 1 | 2001 | 105 | 0.010 |
Why?
|
| Ileum | 1 | 2001 | 169 | 0.010 |
Why?
|
| Interleukin-10 | 1 | 2001 | 166 | 0.010 |
Why?
|
| C-Reactive Protein | 1 | 2001 | 206 | 0.010 |
Why?
|
| Escherichia coli | 1 | 2001 | 627 | 0.010 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2001 | 713 | 0.010 |
Why?
|
| Double-Blind Method | 1 | 2001 | 1791 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2001 | 1973 | 0.010 |
Why?
|
| Sepsis | 1 | 2001 | 391 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2001 | 2534 | 0.010 |
Why?
|
| Time Factors | 1 | 2001 | 5580 | 0.010 |
Why?
|
| Animals | 2 | 2001 | 28891 | 0.010 |
Why?
|